GeneDx Holdings Corp.
NASDAQ:WGS · NASDAQ Global Market
+$1.52 today
Vol 0.66M · Avg 1.28M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-25.97%
Period High
$167.52
Period Low
$34.51
Latest
$59.01
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Kymera Therapeutics, Inc.
NASDAQ:KYMR
$7.43B
Oscar Health, Inc.
NYSE:OSCR
$7.30B
Immunovant, Inc.
NASDAQ:IMVT
$7.11B
Hinge Health, Inc.
NYSE:HNGE
$5.25B
Crinetics Pharmaceuticals, Inc.
NASDAQ:CRNX
$3.74B
Viking Therapeutics, Inc.
NASDAQ:VKTX
$3.53B
NewAmsterdam Pharma Company N.V.
NASDAQ:NAMS
$3.48B
Option Care Health, Inc.
NASDAQ:OPCH
$3.47B
Privia Health Group, Inc.
NASDAQ:PRVA
$2.97B
TransMedics Group, Inc.
NASDAQ:TMDX
$2.74B
What is the latest WGS filing?
The latest filing shown is 8-K dated Jun 16, 2026.
How many recent filings does WGS have?
Intrinsic Alpha currently shows 20 recent filings for WGS.
Explore More
Continue the stock analysis
Jump to another research area for this company.